Prognostic Benefit of Cardiac Magnetic Resonance over Transthoracic Echocardiography for the Assessment of Ischemic and Nonischemic Dilated Cardiomyopathy Patients Referred for the Evaluation of Primary Prevention Implantable Cardioverter-Defibrillator Therapy

Circulation: Cardiovascular Imaging

Volumn 9, Issue 10, 2016, Pages

  Pontone, Gianluca ^a   Guaricci, Andrea I ^b,c   Andreini, Daniele ^a,d   Solbiati, Anna ^d   Guglielmo, Marco ^a   Mushtaq, Saima ^a   Baggiano, Andrea ^a   Beltrama, Virginia ^a   Fusini, Laura ^a   Rota, Cristina ^d   Segurini, Chiara ^a   Conte, Edoardo ^a   Gripari, Paola ^a   Dello Russo, Antonio ^a   Moltrasio, Massimo ^a   Tundo, Fabrizio ^a,d   Lombardi, Federico ^a,e   Muscogiuri, Giuseppe ^f   Lorenzoni, Valentina ^g   Tondo, Claudio ^a   Agostoni, Piergiuseppe ^a,d   Bartorelli, Antonio L ^a,h   Pepi, Mauro ^a   more..

^a CENTRO CARDIOLOGICO MONZINO   (Italy)

^b POLICLINICO   (Italy)

^c UNIVERSITY OF FOGGIA   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^f BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^g SCUOLA SUPERIORE SANT ANNA   (Italy)

^h UNIVERSITY OF MILAN   (Italy)

Author keywords

dilated cardiomyopathy; echocardiography; magnetic resonance; primary prevention; prognosis

Indexed keywords

GADOBENIC ACID; CONTRAST MEDIUM; MEGLUMINE; ORGANOMETALLIC COMPOUND;

ADULT; AGED; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR MAGNETIC RESONANCE; CONGESTIVE CARDIOMYOPATHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; HEART DISEASE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INTERMETHOD COMPARISON; ISCHEMIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; PATIENT REFERRAL; PREDICTIVE VALUE; PRIMARY PREVENTION; PRIORITY JOURNAL; PROGNOSIS; REAL TIME ULTRASOUND SCANNER; SENSITIVITY AND SPECIFICITY; SUDDEN CARDIAC DEATH; TRANSTHORACIC ECHOCARDIOGRAPHY; ANALOGS AND DERIVATIVES; ARRHYTHMIAS, CARDIAC; CARDIOMYOPATHY, DILATED; CARDIOVERSION; CHI SQUARE DISTRIBUTION; CINE MAGNETIC RESONANCE IMAGING; COMPARATIVE STUDY; COMPLICATION; DEATH, SUDDEN, CARDIAC; DEVICES; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART STROKE VOLUME; KAPLAN MEIER METHOD; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RISK FACTOR;

AGED; ARRHYTHMIAS, CARDIAC; CARDIOMYOPATHY, DILATED; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ECHOCARDIOGRAPHY; ELECTRIC COUNTERSHOCK; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MAGNETIC RESONANCE IMAGING, CINE; MALE; MEGLUMINE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; ORGANOMETALLIC COMPOUNDS; PREDICTIVE VALUE OF TESTS; PRIMARY PREVENTION; PROPORTIONAL HAZARDS MODELS; REFERRAL AND CONSULTATION; RISK FACTORS; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 84994065408     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.115.004956     Document Type: Article

References (36)

1. Adabag AS, Luepker RV, Roger VL, Gersh BJ. Sudden cardiac death: epidemiology and risk factors. Nat Rev Cardiol. 2010;7:216-225. doi: 10.1038/nrcardio.2010.3.
2. Myerburg RJ, Kessler KM, Castellanos A. Sudden cardiac death. Structure, function, and time-dependence of risk. Circulation. 1992;85(suppl 1):I2-10.
3. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith SC Jr, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, Blanc JJ, Budaj A, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL; American College of Cardiology/American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006;114:e385-e484. doi: 10.1161/ CIRCULATIONAHA.106.178233.
4. Roes SD, Borleffs CJ, van der Geest RJ, Westenberg JJ, Marsan NA, Kaandorp TA, Reiber JH, Zeppenfeld K, Lamb HJ, de Roos A, Schalij MJ, Bax JJ. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defbrillator. Circ Cardiovasc Imaging. 2009;2:183-190. doi: 10.1161/ CIRCIMAGING.108.826529.
5. Gulati A, Jabbour A, Ismail TF, Guha K, Khwaja J, Raza S, Morarji K, Brown TD, Ismail NA, Dweck MR, Di Pietro E, Roughton M, Wage R, Daryani Y, O'Hanlon R, Sheppard MN, Alpendurada F, Lyon AR, Cook SA, Cowie MR, Assomull RG, Pennell DJ, Prasad SK. Association of f-brosis with mortality and sudden cardiac death in patients with nonisch-emic dilated cardiomyopathy. JAMA. 2013;309:896-908. doi: 10.1001/ jama.2013.1363.
6. Chan RH, Maron BJ, Olivotto I, Pencina MJ, Assenza GE, Haas T, Lesser JR, Gruner C, Crean AM, Rakowski H, Udelson JE, Rowin E, Lombardi M, Cecchi F, Tomberli B, Spirito P, Formisano F, Biagini E, Rapezzi C, De Cecco CN, Autore C, Cook EF, Hong SN, Gibson CM, Manning WJ, Appelbaum E, Maron MS. Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertro-phic cardiomyopathy. Circulation. 2014;130:484-495. doi: 10.1161/ CIRCULATIONAHA.113.007094.
7. Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP, Greene HL, Boczor S, Domanski M, Follmann D, Gent M, Roberts RS. Meta-analysis of the implantable cardioverter defbrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defbrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defbrillator Study. Eur Heart J. 2000;21:2071-2078. doi: 10.1053/euhj.2000.2476.
8. Theuns DA, Smith T, Hunink MG, Bardy GH, Jordaens L. Effectiveness of prophylactic implantation of cardioverter-defbrillators without cardiac resynchronization therapy in patients with ischaemic or non-isch-aemic heart disease: a systematic review and meta-analysis. Europace. 2010;12:1564-1570. doi: 10.1093/europace/euq329.
9. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA III, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO, Tracy CM, Epstein AE, Darbar D, DiMarco JP, Dunbar SB, Estes NA 3rd, Ferguson TB Jr, Hammill SC, Karasik PE, Link MS, Marine JE, Schoenfeld MH, Shanker AJ, Silka MJ, Stevenson LW, Stevenson WG, Varosy PD; American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines; Heart Rhythm Society. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/ HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2013;61:e6-75. doi: 10.1016/j. jacc.2012.11.007.
10. Wang TJ, Evans JC, Benjamin EJ, Levy D, LeRoy EC, Vasan RS. Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation. 2003;108:977-982. doi: 10.1161/01.CIR. 0000085166.44904.79.
11. Felker GM, Shaw LK, O'Connor CM. A standardized defnition of isch-emic cardiomyopathy for use in clinical research. J Am Coll Cardiol. 2002;39:210-218. doi: 10.1016/S0735-1097(01)01738-7.
12. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ; Chamber Quantifcation Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantifcation: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantifcation Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440-1463. doi: 10.1016/j.echo.2005.10.005.
13. Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E; Society for Cardiovascular Magnetic Resonance Board of Trustees Task Force on Standardized Protocols. Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols. J Cardiovasc Magn Reson. 2008;10:35. doi: 10.1186/1532-429X-10-35.
14. Kwong RY, Chan AK, Brown KA, Chan CW, Reynolds HG, Tsang S, Davis RB. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation. 2006;113:2733-2743. doi: 10.1161/CIRCULATIONAHA.105.570648.
15. Gerber BL, Raman SV, Nayak K, Epstein FH, Ferreira P, Axel L, Kraitchman DL. Myocardial frst-pass perfusion cardiovascular magnetic resonance: history, theory, and current state of the art. J Cardiovasc Magn Reson. 2008;10:18. doi: 10.1186/1532-429X-10-18.
16. Masci PG, Schuurman R, Barison A, Ripoli A, Coceani M, Chiappino S, Todiere G, Srebot V, Passino C, Aquaro GD, Emdin M, Lombardi M. Response to letters regarding article, "Myocardial fbrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopa-thy: a contrast-enhanced cardiovascular magnetic study". Circ Cardiovasc Imaging. 2013;6:e79. doi: 10.1161/CIRCIMAGING.113.001217.
17. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML; Multicenter Automatic Defbrillator Implantation Trial II Investigators. Prophylactic implantation of a defbrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883. doi: 10.1056/ NEJMoa013474.
18. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH; Defbrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defbrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004;350:2151-2158. doi: 10.1056/NEJMoa033088.
19. Goldberger JJ, Cain ME, Hohnloser SH, Kadish AH, Knight BP, Lauer MS, Maron BJ, Page RL, Passman RS, Siscovick D, Stevenson WG, Zipes DP; American Heart Association; American College of Cardiology Foundation; Heart Rhythm Society. American Heart Association/ American College of Cardiology Foundation/Heart Rhythm Society scien-tifc statement on noninvasive risk stratifcation techniques for identifying patients at risk for sudden cardiac death. A scientifc statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. J Am Coll Cardiol. 2008;52:1179-1199. doi: 10.1016/j. jacc.2008.05.003.
20. Moss AJ, Greenberg H, Case RB, Zareba W, Hall WJ, Brown MW, Daubert JP, McNitt S, Andrews ML, Elkin AD; Multicenter Automatic Defbrillator Implantation Trial-II (MADIT-II) Research Group. Long-term clinical course of patients after termination of ventricular tachyar-rhythmia by an implanted defbrillator. Circulation. 2004;110:3760-3765. doi: 10.1161/01.CIR.0000150390.04704.B7.
21. Stecker EC, Vickers C, Waltz J, Socoteanu C, John BT, Mariani R, McAnulty JH, Gunson K, Jui J, Chugh SS. Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year fndings from the Oregon Sudden Unexpected Death Study. J Am Coll Cardiol. 2006;47:1161-1166. doi: 10.1016/j.jacc.2005.11.045.
22. Thomson HL, Basmadjian AJ, Rainbird AJ, Razavi M, Avierinos JF, Pellikka PA, Bailey KR, Breen JF, Enriquez-Sarano M. Contrast echo-cardiography improves the accuracy and reproducibility of left ventricular remodeling measurements: a prospective, randomly assigned, blinded study. J Am Coll Cardiol. 2001;38:867-875. doi: 10.1016/ S0735-1097(01)01416-4.
23. Chuang ML, Hibberd MG, Salton CJ, Beaudin RA, Riley MF, Parker RA, Douglas PS, Manning WJ. Importance of imaging method over imaging modality in noninvasive determination of left ventricular volumes and ejection fraction: assessment by two- and three-dimensional echocardiog-raphy and magnetic resonance imaging. J Am Coll Cardiol. 2000;35:477- 484. doi: 10.1016/S0735-1097(99)00551-3.
24. Bellenger NG, Burgess MI, Ray SG, Lahiri A, Coats AJ, Cleland JG, Pennell DJ. Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance. Are they interchangeable? Eur Heart J. 2000;21:387-1396. doi: 10.1053/euhj.2000.2011.
25. Maffei E, Messalli G, Martini C, Nieman K, Catalano O, Rossi A, Seitun S, Guaricci AI, Tedeschi C, Mollet NR, Cademartiri F. Left and right ventricle assessment with Cardiac CT: validation study vs. Cardiac MR. Eur Radiol. 2012;22:1041-1049. doi: 10.1007/s00330-011-2345-6.
26. de Haan S, de Boer K, Commandeur J, Beek AM, van Rossum AC, Allaart CP. Assessment of left ventricular ejection fraction in patients eligible for ICD therapy: discrepancy between cardiac magnetic resonance imaging and 2D echocardiography. Neth Heart J. 2014;22:449-455. doi: 10.1007/ s12471-014-0594-0.
27. Rayatzadeh H, Patel SJ, Hauser TH, Ngo LL, Shaw JL, Tan A, Buxton AE, Zimetbaum P, Josephson ME, Appelbaum E, Manning WJ, Nezafat R. Volumetric left ventricular ejection fraction is superior to 2-dimensional echocardiography for risk stratifcation of patients for primary prevention implantable cardioverter-defbrillator implantation. Am J Cardiol. 2013;111:1175-1179. doi: 10.1016/j.amjcard.2012.12.051.
28. Pontone G, Andreini D, Baggiano A, Bertella E, Mushtaq S, Conte E, Beltrama V, Guaricci AI, Pepi M. Functional relevance of coronary artery disease by cardiac magnetic resonance and cardiac computed tomography: myocardial perfusion and fractional fow reserve. Biomed Res Int. 2015;2015:297696. doi: 10.1155/2015/297696.
29. Guaricci AI, Brunetti ND, Marra MP, Tarantini G, di Biase M, Pontone G. Diagnosis and prognosis of ischemic heart disease: the framework of cardiac magnetic resonance. J Cardiovasc Med (Hagerstown). 2015;16:653- 662. doi: 10.2459/JCM.0000000000000267.
30. Masci PG, Doulaptsis C, Bertella E, Del Torto A, Symons R, Pontone G, Barison A, Droogné W, Andreini D, Lorenzoni V, Gripari P, Mushtaq S, Emdin M, Bogaert J, Lombardi M. Incremental prognostic value of myo-cardial fbrosis in patients with non-ischemic cardiomyopathy without congestive heart failure. Circ Heart Fail. 2014;7:448-456. doi: 10.1161/ CIRCHEARTFAILURE.113.000996.
31. Boyé P, Abdel-Aty H, Zacharzowsky U, Bohl S, Schwenke C, van der Geest RJ, Dietz R, Schirdewan A, Schulz-Menger J. Prediction of life-threatening arrhythmic events in patients with chronic myocar-dial infarction by contrast-enhanced CMR. JACC Cardiovasc Imaging. 2011;4:871-879. doi: 10.1016/j.jcmg.2011.04.014.
32. Kelle S, Roes SD, Klein C, Kokocinski T, de Roos A, Fleck E, Bax JJ, Nagel E. Prognostic value of myocardial infarct size and contractile reserve using magnetic resonance imaging. J Am Coll Cardiol. 2009;54:1770-1777. doi: 10.1016/j.jacc.2009.07.027.
33. Scott PA, Rosengarten JA, Murday DC, Peebles CR, Harden SP, Curzen NP, Morgan JM. Left ventricular scar burden specifes the potential for ventricular arrhythmogenesis: an LGE-CMR study. J Cardiovasc Electrophysiol. 2013;24:430-436. doi: 10.1111/jce.12035.
34. Gao P, Yee R, Gula L, Krahn AD, Skanes A, Leong-Sit P, Klein GJ, Stirrat J, Fine N, Pallaveshi L, Wisenberg G, Thompson TR, Prato F, Drangova M, White JA. Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardiac defbrillator: evaluation of multiple scar quantifcation measures for late gadolinium enhancement magnetic resonance imaging. Circ Cardiovasc Imaging. 2012;5:448-456. doi: 10.1161/CIRCIMAGING.111.971549.
35. Yan AT, Shayne AJ, Brown KA, Gupta SN, Chan CW, Luu TM, Di Carli MF, Reynolds HG, Stevenson WG, Kwong RY. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation. 2006;114:32-39. doi: 10.1161/CIRCULATIONAHA. 106.613414.
36. de Haan S, Meijers TA, Knaapen P, Beek AM, van Rossum AC, Allaart CP. Scar size and characteristics assessed by CMR predict ventricular arrhythmias in ischaemic cardiomyopathy: comparison of previously validated models. Heart. 2011;97:1951-1956. doi: 10.1136/heartjnl-2011-300060.